Showing results (321-330 of 377) with videos related to

Sort By:
Pageof 38
The Journal of Urology|December 1, 1995
Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological AssociationR G Middleton, I M Thompson, M S Austenfeld, et al.
Respiratory Medicine|August 24, 2024
Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registryElizabeth M Webb, Anne E Holland, Anne B Chang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 11, 2011
New clinical diagnostic procedures for cystic fibrosis in EuropeK De Boeck, N Derichs, I Fajac, et al.
Leukemia|September 10, 2005
A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinibL C Crossman, T O'Hare, T Lange, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 2010
HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcomePalanee Ammaranond, David J van Bockel, Kathy Petoumenos, et al.
British Journal of Haematology|September 21, 2000
A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutationsS A Coulthard, C Rabello, J Robson, et al.
Scientific Reports|November 18, 2022
Survival of people with cystic fibrosis in AustraliaRasa Ruseckaite, Farhad Salimi, Arul Earnest, et al.
The Journal of Urology|June 24, 1999
Have complication rates decreased after treatment for localized prostate cancer?I M Thompson, R G Middleton, S A Optenberg, et al.
The Medical Journal of Australia|June 8, 2011
Epidemiology of syphilis in Australia: moving toward elimination of infectious syphilis from remote Aboriginal and Torres Strait Islander communities?James S Ward, Rebecca J Guy, Snehal P Akre, et al.
Lung Cancer (Amsterdam, Netherlands)|September 3, 2013
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancerT Ciuleanu, C-M Tsai, C-J Tsao, et al.
Pageof 38